Journal: Kidney360
Article Title: Dynein-Mediated Trafficking: A New Mechanism of Diabetic Podocytopathy
doi: 10.34067/KID.0006852022
Figure Lengend Snippet: Enhanced dynein-mediated postendocytic trafficking of nephrin in hyperglycemic conditions. (A) In vitro nephrin trafficking assay in mouse podocytes using antibody-mediated cross-linking of nephrin: Nephrin molecules expressed on the podocyte surface were cross-linked by an antinephrin primary antibody and Alexa Fluro 594–labeled secondary antibody, which triggered nephrin internalization and recruitment of trafficking adapters. As demonstrated by Co-IP ((B) by measuring dynein components in nephrin pulldown) and an immunofluorescence colocalization assay ((C) cross-linked nephrin labeled in red by Alexa Fluor 594, Dynll1, and DCTN1 labeled in green by Alexa Fluor 488), HG treatment (HG, 30 mM) increased the recruitment of Dynll1, DCTN1, and HDAC6 to cross-linked nephrin, compared with NG (5.5 mM). These changes could be diminished by inhibiting dynein activity (using Ciliobrevin D, 50 µM) (n=3, *P<0.05 versus HG+0.3% DMSO) or by knocking down Dynll1 in podocytes (n=3, ^P<0.05 versus HG+control siRNA).
Article Snippet: Nephrin Trafficking Model and Time-Lapse Imaging As shown in the schematics in Figure A, cells transfected with the pcDNA3-nephrin plasmid (gift from Dr. Holzman ) were incubated with a mouse antinephrin antibody recognizing the extracellular domain (Santa Cruz #sc-376522), followed by an Alexa Fluor 594-conjugated donkey anti-mouse IgG (Thermo fisher #A32744) to trigger cross-linking and internalization of nephrin.
Techniques: In Vitro, Labeling, Co-Immunoprecipitation Assay, Immunofluorescence, Activity Assay, Control